RIPK1 and lung carcinoma: Another novel RIPK1 inhibitor PK68 which possesses high efficacy and conserved potency among human, mouse, and rat has been reported to effectively inhibit necroptosis and suppress metastasis of both melanoma and lung carcinoma cells in mice [239].